Background Recent guidelines recommend consideration of the use of oral edoxaban or
rivaroxaban for the treatment of venous thromboembolism in patients with cancer. However, the …

Background Data: The epidemiology of venous thromboembolism (VTE) after cancer surgery
is based on clinical trials on VTE prophylaxis that used venography to screen deep vein …

Background Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis
in patients with cancer who are receiving chemotherapy, since these patients are at an …

Patients with venous thromboembolism (VTE), and particularly those with cancer, are at
increased risk of recurrences, major bleeding, and short- / medium-term mortality. Data from …

… Gualberto Gussoni reports no potential conflict of interest. Andrea Fontanella reports no
potential conflict of interest. Menno Huisman has received research grants from ZonMW, …

This prospective, observational and multicentre study assessed the incidence of, and risk
factors for, symptomatic venous thrombotic complications after central venous catheter (CVC) …

Background Direct oral anticoagulants are recommended for the treatment of cancer-associated
thrombosis (CAT) as an alternative to low-molecular-weight heparin (LMWH), but an …

Background Atrial fibrillation (AF) is associated with a high risk of stroke and mortality. Aims
To describe the difference in AF management of patients (pts) referred to Cardiology (CARD) …

Background Internal medicine has been defined as the specialty of the adult medical
complex patients. Complexity science suggests that illness (and health) results from complex, …

Decentralized clinical trials (DCTs) are studies in which the need for patients to physically
access hospital-based trial sites is reduced or eliminated. The CoViD-19 pandemic has …